Kaitlyn D’Onofrio

DocwireNews

<a href="https://www.docwirenews.com/docwire-pick/rheumatology-picks/guselkumab-safe-effective-in-biologic-naive-patients-with-psoriatic-arthritis/">Guselkumab Safe, Effective in Biologic-na&iuml;ve Patients with Psoriatic Arthritis</a><a href="https://www.docwirenews.com/docwire-pick/rheumatology-picks/guselkumab-safe-effective-in-biologic-naive-patients-with-psoriatic-arthritis/">Guselkumab was a safe and effective treatment</a> for biologic-na&iuml;ve patients with psoriatic arthritis (PsA), according to one-year data from a phase 3 study. &ldquo;The overall treatment effect observed during the 24&#8208;week placebo&#8208;controlled period was well maintained, and the risk&ndash;benefit profile remained favorable for both guselkumab regimens, through week 52 of DISCOVER&#8208;2,&rdquo; the researchers summarized in their conclusion.<a href="https://www.docwirenews.com/docwire-pick/rheumatology-picks/ixekizumab-withdrawal-in-psoriatic-arthritis-may-result-in-relapse/">Ixekizumab Withdrawal In Psoriatic Arthritis May Result In Relapse</a>In further PsA news, patients who achieved minimal disease activity on <a href="https://www.docwirenews.com/docwire-pick/rheumatology-picks/ixekizumab-withdrawal-in-psoriatic-arthritis-may-result-in-relapse/">ixekizumab may relapse</a> if they terminate treatment, according to a study. &ldquo;Continued ixekizumab therapy is superior to ixekizumab withdrawal in maintaining low disease activity in biologic&#8208;naive patients with PsA. Retreatment with ixekizumab following relapse may restore disease control in case of treatment interruption,&rdquo; the study authors wrote.<a href="https://www.docwirenews.com/condition-center/orthopedicscc/orthopedics-center-picks/survival-after-hip-fracture-surgery-may-depend-on-how-busy-the-hospital-is/">Survival After Hip Fracture Surgery May Depend On How Busy The Hospital Is</a><a href="https://www.docwirenews.com/condition-center/orthopedicscc/orthopedics-center-picks/survival-after-hip-fracture-surgery-may-depend-on-how-busy-the-hospital-is/">Patients with hip fracture who are admitted to the hospital</a> during a busy time may experience delayed surgery and have a higher risk for 60-day mortality, a study discovered. &ldquo;We found that surgery was delayed in hip fracture patients who were admitted during periods of high volumes of acute surgical admissions. This finding may indicate that hip fracture patients were not prioritized during periods of high activity. The association between high-volume recent acute surgical admissions and longer time to surgery was somewhat attenuated, but still evident after excluding orthopaedic surgery or procedures related to the digestive system from the exposure,&rdquo; the researchers wrote.

Jordana Jampel

FDA Approves Novel Blood Test for Alzheimer’s Detection

Dementia

Andrew Moreno

Is Plasma Mannose-Binding Lectin a Clue to Higher VTE Risk?

Katie Kosko

EMBER-3: Imlunestrant Plus Abemaciclib Improves PFS in ER+ Breast Cancer

HR Breast Cancer

Latest News

Rheum Round-up: Psoriatic Arthritis Medication Research, Hip Fracture Survival

Rheumatology

Guselkumab Safe, Effective in Biologic-naïve Patients with Psoriatic Arthritis ...

About Us

Editorial Policy

Advertising

Contact Us

eNewsletters

Contribute

Career Center

MashupMD

Blood Cancers Today

Cancer Nursing Today

GU Oncology Now

Urban Health Today

Anemia

Deep Vein Thrombosis

Essential Thrombocythemia

Hemophilia

Immune Thrombocytopenic Purpura

Myelodysplastic Syndromes

Myelofibrosis

Myeloproliferative Neoplasms

Polycythemia Vera

Pulmonary Embolism

Sickle Cell Disease

Thrombocytopenia

Thrombophilia

Thrombosis

Thrombotic Thrombocytopenic Purpura

Venous Thromboembolism

von Willebrand Disease

Heme Today

Acute Kidney Injury

ADPKD

Anemia and Kidney Disease

Chronic Kidney Disease

COVID-19 and Kidney Disease

Diabetes and Hypertension

End-Stage Renal Disease

Gout

Hyperkalemia

IgAN

Kidney Transplantation

Metabolic Acidosis

Nephrology Times

HER2 Breast Cancer

Triple-Negative Breast Cancer

Genetics & Breast Cancer

Breast Cancers Today

Atherosclerotic Disease

Atrial Fibrillation

Heart Failure

Hypertension

Interventional Cardiology

Lipid Management

Practice Tips With Dr. Lichaa

Preventive Cardiology

Stroke

Cardiology

Breast Cancer

Gynecologic Cancer

Head and Neck Cancer

Skin Cancer

Oncology

Sleep

Urology

Diabetes

Ophthalmology

— Demodex Blepharitis

Neurology

Gastroenterology

Pulmonology

Infectious Diseases

— HIV

Health and Wellness

Lupus

Future of Medicine

Orthopedics

Pharmacology

Career News

More

Conferences

CardioNerds

The Sleep Source With Dr. Morse

Rheumatology Rounds With Dr. Maheswaranathan

Partners

Expert Interviews

Subscribe